Odyssey Therapeutics, Inc. Common Stock (ODTX) — Net Asset Quality Index
Odyssey Therapeutics, Inc. Common Stock (ODTX) has a Net Asset Quality Index of 87.1% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $483.85 Million minus total liabilities of $62.63 Million yields net assets of $421.22 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore Odyssey Therapeutics, Inc. Common Stock cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Odyssey Therapeutics, Inc. Common Stock Net Asset Quality Index Over Time (2022–2025)
This chart shows how Odyssey Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 87.1%, representing net assets of $421.22 Million against total assets of $483.85 Million USD. See Odyssey Therapeutics, Inc. Common Stock shareholders equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Odyssey Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Odyssey Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ODTX market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -181.0% | $-488.28 Million | $269.79 Million | $758.07 Million | ▲ +12.8 pp |
| 2024 | -193.7% | $-382.53 Million | $197.44 Million | $579.96 Million | ▼ -102.1 pp |
| 2023 | -91.7% | $-262.71 Million | $286.52 Million | $549.23 Million | ▼ -46.1 pp |
| 2022 | -45.6% | $-144.62 Million | $317.15 Million | $461.77 Million | — |